The antioxidant function of PRXD6 reduced the level of ROS in the tumor cells, allowing it to facilitate mitochondrial biosynthesis and oxidative phosphorylation (OXPHOS) processes through both TFAM (mitochondrial transcription factor A)‐dependent and ‐independent pathways, thereby meeting the high energy demands of tumor cell growth. This evidence concerns the gene TFAM and neoplasm.